{"nct_id":"NCT01306643","title":"Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2011-02","start_date_type":null,"primary_completion_date":"2015-08","primary_completion_date_type":"ACTUAL","completion_date":"2015-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}